Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Cucurbitacin I (JSI-124): Precision STAT3 Inhibition Workflo
2026-06-10
Cucurbitacin I (JSI-124) delivers selective, quantitative control of STAT3 signaling for cancer research, enabling robust in vitro and in vivo functional assays. This guide details optimized experimental workflows, data-driven protocol enhancements, and troubleshooting strategies for reliable STAT3 pathway dissection.
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-06-09
This study uncovers that naturally occurring angiotensin peptides, including Angiotensin (1-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, a mechanism likely relevant to COVID-19 pathogenesis. The findings provide mechanistic insight into peptide–receptor interactions and suggest new directions for translational research on viral entry modulation.
Helicase A Orchestrates TH17 Differentiation and Autoimmunit
2026-06-09
This study elucidates how the nuclear helicase Dhx9 (Helicase A) acts as a central regulator of T helper 17 (TH17) lineage differentiation by modulating chromatin accessibility at key cytokine loci. These findings provide a mechanistic framework for understanding TH17-driven autoimmunity and highlight new therapeutic avenues for targeting Dhx9 in immune-mediated diseases.
Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Workflow
2026-06-08
Cy3 NHS ester (non-sulfonated) offers a robust solution for covalent fluorescent labeling of proteins, peptides, and oligonucleotides through primary amine groups, excelling in protocols compatible with organic co-solvents such as DMSO or DMF. Although highly sensitive and reliable for imaging and quantification, its water-insolubility and need for organic solvent use make it unsuitable for strictly aqueous or co-solvent-sensitive workflows.
Tetraethylammonium Chloride: Strategic K+ Channel Blockade f
2026-06-08
This thought-leadership article explores how Tetraethylammonium chloride (TEAC) redefines the toolkit for translational researchers probing potassium channel biology. Integrating mechanistic insight, experimental rigor, and strategic guidance, it details how TEAC's dual-site K+ channel blockade unlocks advanced assay design, informs vascular and metabolic research, and offers a reproducible path from bench to bedside. The narrative weaves in foundational studies, cutting-edge workflow advice, and a critical outlook on clinical translation, while highlighting APExBIO’s product as a gold-standard reagent and referencing leading resources for further depth.
Mildronate-Derived Lipidoids: Advancing mRNA Vaccine Deliver
2026-06-07
The referenced ACS Nano study introduces mildronate-derived cationic lipidoids as an alternative to standard ionizable lipids in mRNA vaccine delivery, achieving efficient in vivo transfection with dramatically reduced inflammatory side effects. These findings inform the development of safer, more effective mRNA-based immunogens for preclinical and translational research.
Obeticholic Acid: Applied FXR Agonism in Liver Fibrosis Mode
2026-06-06
Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) stands out as a powerful FXR agonist for translational liver fibrosis research, enabling rigorous gene regulation studies and modeling of bile acid homeostasis. This article details optimized experimental workflows, practical troubleshooting, and evidence-based innovations from recent advances in immunometabolic liver disease research.
Betaine hydrochloride: Biochemical Precision for Enzyme Rese
2026-06-05
Betaine hydrochloride (carboxymethyl(trimethyl)azanium chloride) is a high-purity, water-soluble reagent used for metabolic enzyme and protease assays. Its physicochemical stability and solubility profile make it a trusted molecular biology supplement. Evidence and protocol recommendations drive its adoption in reproducible biochemical research.
EdU Imaging Kits (Cy3): Precision in S-Phase DNA Synthesis D
2026-06-05
EdU Imaging Kits (Cy3) from APExBIO streamline cell proliferation analysis with click chemistry, delivering denaturation-free, high-sensitivity detection ideal for cancer research and genotoxicity testing. Their workflow preserves cell integrity and offers superior specificity compared to traditional BrdU assays.
Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer
2026-06-04
Gu et al. demonstrate that co-inhibition of CDK4/6 and BET proteins in pancreatic ductal adenocarcinoma (PDAC) synergistically suppresses tumor growth and epithelial-to-mesenchymal transition (EMT) via modulation of the GSK3β-Wnt/β-catenin pathway. These mechanistic insights present a promising combinatorial strategy for overcoming resistance and improving outcomes in pancreatic cancer models.
Ciprofloxacin in Advanced Antimicrobial Resistance Modeling
2026-06-04
Explore how Ciprofloxacin, a potent fluoroquinolone antibiotic, enables next-generation antimicrobial resistance research. This article uncovers advanced assay design, protocol parameters, and practical insights not found in standard workflows.
Streptavidin-FITC: Precision Biotin Detection for Advanced A
2026-06-03
Streptavidin-FITC empowers researchers with ultra-sensitive, quantitative detection of biotinylated molecules across imaging and cytometry workflows. Explore evidence-driven protocol enhancements, troubleshooting strategies, and innovations from recent lipid nanoparticle trafficking studies that unlock new assay capabilities.
Ciprofloxacin: Mechanism, Evidence, and Research Integration
2026-06-03
Ciprofloxacin is a well-characterized fluoroquinolone antibiotic that acts as a DNA gyrase inhibitor, crucial for antimicrobial resistance research. Its potent, defined mechanism and high-purity availability from APExBIO make it a benchmark compound for laboratory investigations into bacterial DNA replication inhibition.
Redox-Responsive Peptide Coacervates Advance mRNA Delivery
2026-06-02
This study introduces a minimalist, redox-responsive peptide coacervate (HBpep-SS4) that achieves high-efficiency mRNA encapsulation and cytosolic release, outperforming previous peptide-based systems in stability and control. The findings have broad implications for developing safer, more effective platforms for mRNA delivery and intracellular gene regulation.
Maraviroc (UK-427857): Applied Workflows for CCR5 Antagonism
2026-06-02
Maraviroc (UK-427857) enables high-fidelity inhibition of CCR5, unlocking advanced assays for HIV-1 entry, neuroinflammation, and novel RA models. This guide translates recent breakthroughs into actionable workflows and troubleshooting insights, making APExBIO’s Maraviroc a cornerstone for translational immunology.
8403 records 19/561 page Previous Next First page 上5页 1617181920 下5页 Last page